OC
BRLI

Oppenheimer & Co’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Oppenheimer & Co’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-35,272
Closed -$901K – 1523
2013
Q4 		$901K Buy
35,272
+82
+0.2% +$2.53K 0.03% 598
2013
Q3 		$1.05M Buy
35,190
+8,915
+34% +$248K 0.04% 515
2013
Q2 		$755K Buy
+26,275
New +$724K 0.03% 590

Other funds holding BRLI

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Oppenheimer & Co's BRLI Position: Q1 2014 in Review

Oppenheimer & Co sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q1 2014, closing a stake of 35,272 shares — an estimated $901K sold.

Oppenheimer & Co first reported a position in BRLI in Q2 2013 and held it in 3 quarters. The position peaked at $1.05M in Q3 2013. 162 funds tracked by Wall St. Rank hold BRLI as of Q1 2014.

  • Oppenheimer & Co reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q1 2014 after selling out during the quarter.
  • Oppenheimer & Co sold 35,272 BIO-REFERENCE LABS INC-NEW- shares in Q1 2014, an estimated $901K.
  • Oppenheimer & Co first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 3 quarters.
  • Oppenheimer & Co's BIO-REFERENCE LABS INC-NEW- position peaked at $1.05M in Q3 2013.
  • 162 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2014.

Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.